10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the quarterly period ended September 30, 2007

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the transition period from                      to                     .

Commission File Number 333-80337

Team Finance LLC

(Exact name of registrant as specified in its charter)

Delaware	8099	20-3818106
(State or other jurisdiction of incorporation or organization)	(Primary Standard Industrial Classification Code Number)	(I.R.S. Employer Identification No.)

Health Finance Corporation

(Exact name of registrant as specified in its charter)

Delaware	8099	20-3818041
(State or other jurisdiction of incorporation or organization)	(Primary Standard Industrial Classification Code Number)	(I.R.S. Employer Identification No.)

1900 Winston Road

Suite 300

Knoxville, Tennessee 37919

(865) 693-1000

(Address, zip code, and telephone number, including area code, of registrant’s principal executive office.)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 and 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes  þ    No  ¨

Indicate by check mark whether the registrants are large accelerated filers, accelerated filers, or non-accelerated filers. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  ¨            Accelerated filer  ¨            Non-accelerated filer  þ

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)

Yes  ¨    No  þ

As of November 7, 2007, there were outstanding 1,000 Class A Units of Team Finance LLC and 100 shares of Common Stock, with a par value of $.01 of Health Finance Corporation.

FORWARD LOOKING STATEMENTS

Statements made in this Form 10-Q that are not historical facts and that reflect the current view of Team Finance LLC and Team Health, Inc. (collectively, the “Company”) about future events and financial performance are hereby identified as “forward looking statements.” Some of these statements can be identified by terms and phrases such as “anticipate,” “believe,” “intend,” “estimate,” “expect,” “continue,” “could,” “should”, “may,” “plan,” “project,” “predict” and similar expressions and include references to assumptions that we believe are reasonable and relate to our future prospects, developments and business strategies. The Company cautions readers of this Form 10-Q that such “forward looking statements”, including without limitation, those relating to the Company’s future business prospects, revenue, working capital, professional liability expense, liquidity, capital needs, interest costs and income, wherever they occur in this Form 10-Q or in other statements attributable to the Company, are necessarily estimates reflecting the judgment of the Company’s senior management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the “forward looking statements”. Factors that could cause our actual results to differ materially from those expressed or implied in such forward-looking statements, include, but are not limited to:

• the effect and interpretation of current or future government regulation of the healthcare industry, and our ability to comply with these regulations;

• our exposure to professional liability lawsuits and governmental agency investigations;

• the adequacy of our insurance coverage and insurance reserves;

• our reliance on third-party payers;

• the general level of emergency department patient volumes at our clients’ facilities;

• our ability to enter into and retain contracts with hospitals, military treatment facilities and other healthcare facilities on attractive terms;

• changes in rates or methods of government payments for our services;

• our ability to successfully integrate strategic acquisitions;

• the control of our company by our sponsor may be in conflict with our interests;

• our future capital needs and ability to obtain future financing;

• our ability to carry out our business strategy;

• our ability to continue to recruit and retain qualified healthcare professionals and our ability to attract and retain operational personnel;

• competition in our market;

• our ability to maintain or implement complex information systems;

• our substantial indebtedness;

• our ability to generate cash flow to service our debt obligations;

• certain covenants in our debt documents;

• general economic conditions; and

• other factors detailed from time to time in the Company’s filings with the Securities and Exchange Commission, including filings on Forms 10-Q and 10-K.

The Company disclaims any intent or obligation to update “forward looking statements” made in this Form 10-Q to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time.

2

TEAM FINANCE LLC

QUARTERLY REPORT FOR THE THREE MONTHS

ENDED SEPTEMBER 30, 2007

		Page
Part 1. Financial Information
Item 1.	Financial Statements (Unaudited)
	Consolidated Balance Sheets—September 30, 2007 and December 31, 2006	4
	Consolidated Statements of Operations—Three months ended September 30, 2007 and 2006	5
	Consolidated Statements of Operations—Nine months ended September 30, 2007 and 2006	6
	Consolidated Statements of Cash Flows—Nine months ended September 30, 2007 and 2006	7
	Notes to Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	35
Item 4.	Controls and Procedures	36
Part 2. Other Information
Item 1.	Legal Proceedings	36
Item 1A.	Risk Factors	36
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	36
Item 3.	Defaults Upon Senior Securities	36
Item 4.	Submission of Matters to a Vote of Security Holders	36
Item 5.	Other Information	36
Item 6.	Exhibits	37
Signatures		38

3

PART 1. FINANCIAL INFORMATION

Item 1. Financial Statements

TEAM FINANCE LLC

CONSOLIDATED BALANCE SHEETS

	September 30, 2007			December 31, 2006
	(Unaudited)
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	19,807		$	3,999
Accounts receivable, less allowance for uncollectibles of $166,482 and $168,416 in 2007 and 2006, respectively		227,815			207,031
Prepaid expenses and other current assets		17,527			11,463
Receivables under insurance programs		24,644			36,287
Income tax receivable		—			1,403
Total current assets		289,793			260,183
Investments of insurance subsidiary		69,264			59,809
Property and equipment, net		25,821			21,847
Other intangibles, net		28,796			29,051
Goodwill		148,361			150,459
Deferred income taxes		74,702			86,726
Receivables under insurance programs		30,361			23,213
Other		29,433			23,272
	$	696,531		$	654,560
LIABILITIES AND MEMBERS’ EQUITY (DEFICIT)
Current liabilities:
Accounts payable	$	11,185		$	13,618
Accrued compensation and physician payable		97,919			86,410
Other accrued liabilities		78,975			76,855
Income tax payable		3,439			—
Current maturities of long-term debt		4,250			11,050
Deferred income taxes		28,153			22,673
Total current liabilities		223,921			210,606
Long-term debt, less current maturities		628,312			631,500
Other non-current liabilities		170,553			179,144
Accumulated other comprehensive gain (loss)		255			(276	)
Members’ deficit		(326,510	)		(366,414	)
	$	696,531		$	654,560

See accompanying notes to financial statements.

4

TEAM FINANCE LLC

CONSOLIDATED STATEMENTS OF OPERATIONS

	Three Months Ended September 30,
	2007			2006
	(Unaudited)
	(In thousands)
Net revenue	$	550,949		$	481,033
Provision for uncollectibles		236,345			197,749
Net revenue less provision for uncollectibles		314,604			283,284
Cost of services rendered
Professional service expense		241,400			215,493
Professional liability cost		1,052			12,825
Gross profit		72,152			54,966
General and administrative expenses		28,496			26,143
Management fee and other expenses		1,217			877
Depreciation and amortization		3,868			6,109
Interest expense, net		13,639			15,205
Earnings from continuing operations before income taxes		24,932			6,632
Provision for income taxes		9,352			2,235
Earnings from continuing operations		15,580			4,397
Earnings (loss) from discontinued operations less applicable (benefit from) provision for income taxes of ($95) and $66, respectively		(152	)		105
Net earnings	$	15,428		$	4,502

See accompanying notes to financial statements.

5

TEAM FINANCE LLC

CONSOLIDATED STATEMENTS OF OPERATIONS

	Nine Months Ended September 30,
	2007			2006
	(Unaudited)
	(In thousands)
Net revenue	$	1,555,082		$	1,346,624
Provision for uncollectibles		636,570			537,980
Net revenue less provision for uncollectibles		918,512			808,644
Cost of services rendered
Professional service expense		703,412			613,337
Professional liability cost		7,266			24,496
Gross profit		207,834			170,811
General and administrative expenses		83,310			74,986
Management fee and other expenses		3,035			2,690
Depreciation and amortization		10,956			19,879
Interest expense, net		41,430			43,117
Earnings from continuing operations before income taxes		69,103			30,139
Provision for income taxes		26,552			11,600
Earnings from continuing operations		42,551			18,539
Loss from discontinued operations less applicable benefit from income taxes of $312 and $2,386, respectively		(499	)		(6,904	)
Net earnings	$	42,052		$	11,635

See accompanying notes to financial statements.

6

TEAM FINANCE LLC

CONSOLIDATED STATEMENTS OF CASH FLOWS

	Nine Months Ended September 30,
	2007			2006
	(Unaudited)
	(In thousands)
Operating Activities
Net earnings	$	42,052		$	11,635
Adjustments to reconcile net earnings:
Depreciation and amortization		10,994			20,462
Amortization of deferred financing costs		1,615			1,821
Employee equity based compensation expense		419			477
Provision for uncollectibles		636,570			537,980
Impairment of intangibles		—			9,523
Deferred income taxes		19,441			(2,561	)
Loss on sale of equipment		407			23
Equity in joint venture income		(1,360	)		(1,502	)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable		(657,354	)		(552,012	)
Prepaids and other assets		(12,101	)		(13,108	)
Income tax accounts		4,207			17,526
Accounts payable		(2,433	)		(9,095	)
Accrued compensation and physician payable		12,979			987
Other accrued liabilities		5,717			4,900
Professional liability reserves		(10,693	)		4,449
Net cash provided by operating activities		50,460			31,505
Investing Activities
Purchases of property and equipment		(10,865	)		(7,173	)
Cash paid for acquisitions, net		(3,545	)		(20,785	)
Net purchases of investments by insurance subsidiary		(8,925	)		(12,640	)
Other investing activities		125			209
Net cash used in investing activities		(23,210	)		(40,389	)
Financing Activities
Payments on notes payable		(3,188	)		(3,187	)
Proceeds from revolving credit facility		83,000			184,300
Payments on revolving credit facility		(89,800	)		(176,700	)
Payments of deferred financing costs		(500	)		(752	)
Purchase of treasury stock		—			(2,570	)
Proceeds from sales of common units		50			115
Redemption of common units		(1,004	)		—
Transaction payments in connection with recapitalization		—			(56	)
Net cash (used in) provided by financing activities		(11,442	)		1,150
Net increase (decrease) in cash		15,808			(7,734	)
Cash and cash equivalents, beginning of period		3,999			10,644
Cash and cash equivalents, end of period	$	19,807		$	2,910
Interest paid	$	37,306		$	37,303
Taxes paid	$	2,089		$	4,494

See accompanying notes to financial statements.

7

TEAM FINANCE LLC

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1. Organization and Basis of Presentation

On November 23, 2005, affiliates of The Blackstone Group (“Blackstone”), a private equity firm, by way of merger with Team Health Holdings LLC (“Holdings”), acquired a 91.1% interest in Holdings (the “Recapitalization Merger”). Holdings became the parent corporation of Team Finance LLC (“Team Finance”). Also pursuant to the Merger Agreement dated October 11, 2005, Team MergerSub Inc., a Tennessee Corporation and wholly-owned subsidiary of Team Finance merged with and into Team Health, Inc. (“Team Health”) (the “Reorganization Merger”). References and information noted as being those of the “Company”, “we” or “our” relate to both Team Health and Team Finance. The remaining ownership in Holdings is held by members of management of the Company.

The Recapitalization Merger was accounted for as a recapitalization. The Reorganization Merger was accounted for as an acquisition of minority interest, whereby the common stock of Team Health that was not owned by Holdings prior to November 23, 2005, was recorded at fair value resulting in an adjustment to the carrying value of the pro rata portion of assets and liabilities deemed to have been acquired or assumed in the Reorganization Merger. Pursuant to the Reorganization Merger, all the existing outstanding minority equity interests in Team Health was acquired by Holdings, resulting in Holdings owning 100% of the outstanding equity interests in Team Health. In 1999, our former controlling stockholders acquired their controlling interest in Team Health in a transaction that was also accounted for as a recapitalization (the “1999 Recapitalization”). The Reorganization Merger also required the “push down” of the accounting basis established in the 1999 Recapitalization. Accordingly, the historical information for Team Health was restated for the effect of the Reorganization Merger for the purpose of presenting these consolidated financial statements of Team Finance.

The accompanying unaudited consolidated financial statements include the accounts of Team Health and its wholly owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States for interim financial reporting and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by accounting principles generally accepted in the United States for complete financial statements. Certain prior year amounts have been reclassified to conform to the current year presentation.

In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments (consisting of normal recurring items) necessary for a fair presentation of results for the interim periods presented. The results of operations for any interim period are not necessarily indicative of results for the full year. The consolidated balance sheet of the Company at December 31, 2006 has been derived from the audited financial statements at that date, but does not include all of the information and disclosures required by accounting principles generally accepted in the United States for complete financial statements. These financial statements and footnote disclosures should be read in conjunction with the December 31, 2006 audited consolidated financial statements and the notes thereto included in the Company’s Form 10-K filed with the Securities and Exchange Commission on March 13, 2007.

The preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying consolidated financial statements and notes. Actual results could differ from those estimates.

Note 2. New Accounting Standards

In September 2006, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards (“SFAS”) No. 157, “Fair Value Measurements,” which provides enhanced guidance for

8

using fair value to measure assets and liabilities. SFAS No. 157 establishes a common definition of fair value, provides a framework for measuring fair value under U.S. GAAP and expands disclosure requirements about fair value measurements. SFAS No. 157 is effective for financial statements issued in fiscal years beginning after November 15, 2007, and interim periods within those fiscal years. The Company is currently evaluating the impact, if any, the adoption of SFAS No. 157 will have on the Company’s financial reporting and disclosures.

In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities—Including an amendment of FASB Statement No. 115 (“SFAS 159”). SFAS 159 permits entities to measure eligible assets and liabilities at fair value. Unrealized gains and losses on items for which the fair value option has been elected are reported in earnings. SFAS 159 is effective for fiscal years beginning after November 15, 2007. The provisions of SFAS 159 will become effective on January 1, 2008, and the Company has not yet determined the impact, if any, on its consolidated financial statements.

Note 3. Discontinued Operations

In January 2007, the Company completed a strategic review of Team Health Anesthesiology Management Services (“THAMS”), and based upon the review, concluded that the existing business model of providing management services to independent physician groups was not a viable long term strategy and could not consistently meet internal growth targets. As a result of this review, the Company elected to exit this non-core business line. The final phase of this business line disposal was substantially completed during the third quarter of 2007, therefore in accordance with the provisions of SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets the operating results of THAMS are presented in the accompanying consolidated statements of operations as a discontinued operation for all periods presented.

The financial results of THAMS included in discontinued operations, are as follows (in thousands):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2007			2006		2007			2006
Net revenue	$	49		$	2,800	$	2,368		$	9,124
Total cost of services		(11	)		560		398			2,060
Gross Profit		60			2,240		1,970			7,064
Earnings (loss) before income taxes		(247	)		171		(811	)		(9,290	)
Provision for (benefit from) income taxes		(95	)		66		(312	)		(2,386	)
Earnings (loss) from discontinued operations	$	(152	)	$	105	$	(499	)	$	(6,904	)

The loss from discontinued operations in the three and nine months ended September 30, 2007 include approximately $0.1 million and $1.0 million, respectively, of severance and other exit costs related to the disposal of this business unit.

The loss from discontinued operations in the nine months ended September 30, 2006 consists of an impairment loss of $9.5 million ($7.0 million net of $2.5 million tax benefit). In April 2006, THAMS received notification from its largest anesthesia practice client of its intent to terminate its contract in accordance with the terms of the agreement. Management concluded that THAMS’ existing revenues and operating income would be materially adversely affected as a result of this contract termination. The above noted facts and circumstances were concluded by management to require a test for recoverability of the existing contract intangibles under the provisions of SFAS No. 144 “Accounting for the Impairment or Disposal of Long-Lived Assets” and a “triggering event” under the provisions of SFAS No. 142 “Goodwill and Other Intangible Assets.” Consequently the Company recorded a charge of $2.0 million in the results of operations in the first quarter of 2006. The charge reduced the book value of the contract intangibles within the management services reporting segment to its fair value estimated to be $0.7 million as of March 31, 2006, as determined by using a discounted cash flow model.

9

Additionally, the Company recorded a goodwill impairment loss of $7.5 million in the first quarter of 2006. The estimated impairment was determined following the provisions of SFAS No. 142. Accordingly, the Company initially estimated the fair value of THAMS. The fair value of the business was determined using a multiple of projected cash flows on remaining contracts. The carrying value of the business exceeded its fair market value. The estimated fair value was allocated to the underlying net assets of the business following generally accepted accounting principles for allocating purchase prices. This included an allocation of value to the components of working capital, contract intangibles (based on discounting of future cash flows estimated to be derived from such contracts) with the remainder of such fair value assigned to goodwill. The estimate of the implied goodwill resulting from the aforementioned application of the principles outlined in SFAS No. 142 was less than the recorded goodwill related to THAMS.

For the nine months ended September 30, 2007 and 2006 THAMS had an operating use of cash of $1.3 million and $0.9 million, respectively.

Note 4. Acquisitions

Effective August 24, 2007, the Company completed the acquisition of certain assets and related business operations of an emergency medicine staffing business located in Florida. The purchase price for the acquired business was $2.4 million which was paid in cash on the date of the closing. In addition, the Company may have to pay up to $2.2 million in future contingent payments. In connection with the transaction the Company has recorded a $4.3 million contract intangible, which is the estimated fair value of the assets acquired at the date of the acquisition. The excess of fair value of the assets acquired compared to the amount paid as of the acquisition date has been reflected as “estimated amount due seller” in accordance with SFAS No. 141, Business Combinations. Any contingent consideration payable in the future will be first applied to reduce the amount recorded as “estimated amount due seller,” and thereafter to goodwill.

Effective May 1, 2006, the Company acquired the operations of two businesses. The acquired companies provide hospital emergency department and hospital physician staffing services under eleven contracts for locations in Ohio. The purchase price for the acquired companies was $4.0 million of which $3.0 million was paid in cash at May 1, 2006 and $1.0 million in assumed liabilities. The purchase price was allocated to contract intangibles based on the estimated fair value of the contracts obtained on the acquisition date.

Effective July 1, 2006, the Company completed the acquisition of certain assets and related business operations of a hospital medicine and inpatient services business located in Florida. The purchase price for the acquired business was $17.9 million which was paid in cash on the date of the closing. In addition, the Company may have to pay up to $9.6 million in future contingent payments. Of the total purchase price, $6.6 million was allocated to contract intangibles based on the estimated fair value of the contracts obtained on the acquisition date. The remaining $11.3 million was recorded as goodwill.

Note 5. Net Revenue

Net revenue for the three and nine months ended September 30, 2007 and 2006, respectively, consisted of the following (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2007		2006		2007		2006
Fee for service revenue	$	443,981	$	373,821	$	1,233,514	$	1,049,071
Contract revenue		100,972		99,275		303,031		279,442
Other revenue		5,996		7,937		18,537		18,111
	$	550,949	$	481,033	$	1,555,082	$	1,346,624

10

Note 6. Other Intangible Assets

The following is a summary of intangible assets and related amortization as of September 30, 2007 and December 31, 2006 (in thousands):

	Gross Carrying Amount		Accumulated Amortization
As of September 30, 2007:
Contracts	$	40,020	$	11,327
Other		448		345
Total	$	40,468	$	11,672
As of December 31, 2006:
Contracts	$	37,323	$	8,409
Other		448		311
Total	$	37,771	$	8,720
Aggregate amortization expense:
For the nine months ended September 30, 2007	$	4,512
Estimated amortization expense:
For the remainder of the year ended December 31, 2007	$	1,485
For the year ended December 31, 2008		5,756
For the year ended December 31, 2009		5,673
For the year ended December 31, 2010		5,416
For the year ended December 31, 2011		5,416

Note 7. Income Taxes

In June 2006, FASB issued Interpretation No. 48, “Accounting for Uncertainty in Income Taxes”, an interpretation of FAS 109, “Accounting for Income Taxes” (FIN 48), to create a single model to address accounting for uncertainty in tax positions. FIN 48 clarifies the accounting for income taxes, by prescribing a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. FIN 48 also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. FIN 48 became effective for fiscal years beginning after December 15, 2006.

The Company adopted the provisions of FIN 48 on January 1, 2007. As a result of the implementation of FIN 48, the Company recognized approximately a $1.6 million charge to members’ equity, a reduction in the deferred tax assets of approximately $1.0 million and an increase in the liability for unrecognized tax benefits of approximately $0.4 million. The Company recognizes interest accrued related to the unrecognized tax benefits in interest expense and penalties in operating expenses. Included in the above estimates is approximately $0.2 million of interest expense.

During the three months ended September 30, 2007, the Company recognized an additional reduction of its deferred tax asset of approximately $0.1 million and an increase in the liability for unrecognized tax benefits of approximately $0.4 million, $0.2 million related to a position taken in a prior period.

The amount of unrecognized tax benefits that, if recognized, would affect the effective rate are approximately $2.2 million.

The Company and its subsidiaries file income tax returns in the U. S. federal jurisdiction and various state jurisdictions. With few exceptions, the Company is no longer subject to U. S. federal, state or local examination by tax authorities for years before 2003.

11

The effective rate for continuing operations for the nine months ended September 30, 2007 was 38.4% compared to 38.5% for the same period in 2006.

Note 8. Long-Term Debt

Long-term debt as of September 30, 2007 consisted of the following (in thousands):

Term Loan Facilities	$	417,562
11.25% Senior Subordinated Notes		215,000
Revolving line of credit		—
		632,562
Less current portion		(4,250	)
	$	628,312

The interest rate for any revolving credit facility borrowings is based on a grid which is based on the consolidated ratio of total funded debt to earnings before interest, taxes, depreciation and amortization, all as set forth in the credit agreement. As of September 30, 2007, the interest rate for borrowings under the revolving credit facility was equal to the euro dollar rate plus 2.25% or the agent bank’s base rate plus 1.25%. In addition, the Company pays a commitment fee for the revolving credit facility which is equal to 0.5% of the commitment at September 30, 2007.

The interest rate at September 30, 2007 was 7.4% for amounts outstanding under the term loan facility. Effective April 5, 2007, the Company amended its senior credit agreement. The amendment reduced the interest rate on any term loans outstanding equal to the euro dollar rate plus 2.0% or the agent bank’s base rate plus 1.0%. Previously, the interest rate on term loan borrowings was equal to the euro dollar rate plus 2.50% or the agent bank’s base rate plus 1.50%. The Company is subject to an increase in the term loan interest rate in the amount of 0.25% in the event of a downgrade in the corporate family rating of the Company by either Moody’s or Standard and Poor’s rating agencies. In addition, prior to April 5, 2008, in the event of a prepayment of the outstanding term loans associated with a refinancing whose primary purpose is a reduction in the term loan interest rate, the Company will pay a fee equal to 1.0% of the prepayment amount. Other significant terms and conditions of the credit agreement, including the maturity date of November 23, 2012, did not change under the amendment.

No borrowings under the $125.0 million revolving credit facility were outstanding as of September 30, 2007, and the Company had $7.1 million of standby letters of credit outstanding against the revolving credit facility commitment.

The Company issued on November 23, 2005, 11.25% Senior Subordinated Notes (the “Notes”) in the amount of $215.0 million due December 1, 2013. The Notes are subordinated in right of payment to all senior debt of the Company and are senior in right of payment to all existing and future subordinated indebtedness of the Company. Interest on the Notes accrues at the rate of 11.25% per annum, payable semi-annually in arrears on June 1 and December 1 of each year. Beginning on December 1, 2009, the Company may redeem some or all of the Notes at any time at various redemption prices.

The Notes are guaranteed jointly and severally on a full and unconditional basis by all of the Company’s domestic wholly-owned operating subsidiaries (the “Subsidiary Guarantors”) as required by the Indenture Agreement.

Both the 11.25% Notes and the current term loan facility contain both affirmative and negative covenants, including limitations on the Company’s ability to incur additional indebtedness, sell material assets, retire, redeem or otherwise reacquire its capital stock, acquire the capital stock or assets of another business, pay dividends, and require the Company to comply with certain coverage and leverage ratios.

12

Aggregate annual maturities of long-term debt as of September 30, 2007 are as follows (in thousands):

2007	$	4,250
2008		4,250
2009		4,250
2010		4,250
2011		4,250
Thereafter		611,312

Note 9. Professional Liability Insurance

The Company’s professional liability loss reserves consist of the following (in thousands):

	September 30, 2007			December 31, 2006
Estimated losses under self-insured programs	$	159,819		$	170,512
Estimated losses under commercial insurance programs		55,004			59,500
		214,823			230,012
Less estimated payable within one year		(56,876	)		(59,486	)
	$	157,947		$	170,526

The Company provides for its estimated professional liability losses through a combination of self-insurance and commercial insurance programs. During the period March 12, 1999 through March 11, 2003, the primary source of the Company’s coverage for such risks was a professional liability insurance policy provided through one insurance carrier. The commercial insurance carrier policy initially included an insured loss limit of $130.0 million. In April 2006, the Company amended the policy with its commercial insurance carrier to provide for an increase in the aggregate limit of coverage based upon certain premium funding levels. As of September 30, 2007, the insured loss limit under the policy was $146.0 million. Losses in excess of the limit of coverage remain as a self-insured obligation of the Company. Beginning March 12, 2003, professional liability loss risks are principally being provided for through self-insurance with a portion of such risks (“claims-made” basis) transferred to and funded into a captive insurance company. The accounts of the captive insurance company are fully consolidated with those of the other operations of the Company in the accompanying consolidated financial statements.

The self-insurance components of our risk management program include reserves for future claims incurred but not reported. The Company’s provisions for losses under its self-insurance components are estimated using the results of periodic actuarial studies performed by an independent actuarial firm. Such actuarial studies include numerous underlying estimates and assumptions, including assumptions as to future claim losses, the severity and frequency of such projected losses, loss development factors and others. The Company’s provisions for losses under its self-insured components are subject to subsequent adjustment should future actuarial projected results for such periods indicate projected losses greater or less than previously projected.

The Company’s most recent actuarial valuation was completed in October 2007. As a result of such actuarial valuation, the Company realized a reduction in its provision for professional liability losses of $12.5 million in the three months ended September 30, 2007, related to its reserves for losses in prior years. Additionally, the Company had realized a $19.6 million reduction in its professional liability losses in the first quarter of 2007, resulting from an actuarial study completed in April 2007. In total, for the nine months ended September 30, 2007, the Company has realized a reduction in its provision for professional liability losses of $32.1 million related to reserves for loss estimates in prior years associated with favorable trends in actuarial loss estimates. Also in the nine months ended September 30, 2006, the Company realized a $12.1 million reduction in its professional liability losses resulting from an actuarial study completed in April 2006.

13

Note 10. Share-based Compensation

On January 1, 2006, the Company adopted SFAS No. 123(R), Share-Based Payment—Revised 2000 (SFAS No. 123(R)).

In November 2005, the Company adopted the 2005 Unit Plan. A total of 400,000 Class B Common Units and 600,000 Class C Common Units are authorized for issuance to executives and other key employees under the 2005 Unit Plan. As of September 30, 2007, there were 307,833 restricted Class B Common Units and 430,967 Class C Common Units outstanding. The outstanding units vest ratably over five years and the Company is recognizing the related compensation expense over the five year period. Compensation expense for the employee equity based awards granted is based on the grant date fair value in accordance with the provisions of SFAS No. 123(R). For the nine months ended September 30, 2007 and 2006, the Company recognized $0.5 million, of employee equity based compensation expense. As of September 30, 2007, there was $1.8 million of unrecognized compensation expense related to nonvested restricted unit awards, which will be recognized over the remaining requisite service period. Forfeitures of employee equity based awards have been historically immaterial to the Company.

Also, in connection with the issuance of the restricted units, the Company recognized a tax benefit of approximately $1.0 million in 2006.

Note 11. Contingencies

Litigation

We are currently a party to various legal proceedings. While we currently believe that the ultimate outcome of such proceedings, individually and in the aggregate, will not have a material adverse effect on our financial position or overall trends in results of operations, litigation is subject to inherent uncertainties. If an unfavorable ruling were to occur, there exists the possibility of a material adverse impact on our net earnings in the period in which a ruling occurs. The estimate of the potential impact from such legal proceedings on our financial position or overall results of operations could change in the future.

Healthcare Regulatory Matters

Laws and regulations governing the Medicare and Medicaid programs are complex and subject to interpretation. Compliance with such laws and regulations can be subject to future governmental review and interpretation as well as significant regulatory action. From time to time, governmental regulatory agencies will conduct inquiries and audits of the Company’s practices. It is the Company’s current practice and future intent to cooperate fully with such inquiries.

In addition to laws and regulations governing the Medicare and Medicaid programs, there are a number of federal and state laws and regulations governing such matters as the corporate practice of medicine and fee splitting arrangements, anti-kickback statutes, physician self-referral laws, false or fraudulent claims filing and patient privacy requirements. The failure to comply with any of such laws or regulations could have an adverse impact on our operations and financial results. It is management’s belief that the Company is in substantial compliance in all material respects with such laws and regulations.

Acquisition Payments

As of September 30, 2007, the Company may have to pay up to $11.8 million in future contingent payments as additional consideration for acquisitions made prior to September 30, 2007. These payments will be made and recorded as additional purchase price or will reduce existing liabilities should the acquired operations achieve the financial targets agreed to in the respective acquisition agreements. During the nine months ended September 30, 2007, the Company made $1.1 million in cash payments related to previous acquisitions.

14

Note 12. Comprehensive Earnings

The components of comprehensive earnings, net of related taxes, are as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2007		2006		2007		2006
Net earnings	$	15,428	$	4,502	$	42,052	$	11,635
Net change in fair market value of investments		660		355		531		11
Comprehensive earnings	$	16,088	$	4,857	$	42,583	$	11,646

Note 13. Segment Reporting

After consideration of the discontinued operations of its anesthesia management services business (Note 3), the Company provides services through four operating segments which are aggregated into two reportable segments, Healthcare Services and Billing Services. The Healthcare Services segment, which is an aggregation of healthcare staffing, clinics and occupational health, provides comprehensive healthcare service programs to users and providers of healthcare services on a fee-for-service as well as a cost plus basis. The Billing Services segment provides a range of external billing, collection and consulting services on a fee basis to outside third-party customers.

Segment amounts disclosed are prior to any elimination entries made in consolidation, except in the case of net revenue, where intercompany charges have been eliminated. Certain expenses are not allocated to the segments. These unallocated expenses are corporate expenses, net interest expense, depreciation and amortization, refinancing costs and income taxes. The Company evaluates segment performance based on profit and loss before the aforementioned expenses.

The following table presents financial information for each reportable segment. Depreciation, amortization, management fee and other expenses separately identified in the consolidated statements of operations are included as a reduction to the operating earnings of each segment in each period below (in thousands):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2007			2006			2007			2006
Net Revenue less provision for uncollectibles:
Healthcare Services	$	311,696		$	280,259		$	909,464		$	800,131
Billing Services		2,908			3,025			9,048			8,513
	$	314,604		$	283,284		$	918,512		$	808,644
Operating earnings:
Healthcare Services	$	50,065		$	31,926		$	144,261		$	102,921
Billing Services		461			791			1,499			2,178
General Corporate		(11,955	)		(10,880	)		(35,227	)		(31,843	)
	$	38,571		$	21,837		$	110,533		$	73,256

Note 14. Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiary

The Company conducts substantially all of its business through its subsidiaries. The parent company is a holding company that conducts no operations and whose financial position, excluding its investments in its subsidiaries, is comprised of deferred financing costs and the Company’s debt. The Company’s domestic, wholly-owned subsidiaries jointly and severally guarantee the 11.25% Notes on an unsecured senior

15

subordinated basis. The condensed consolidating financial information for the parent company, the issuers of the 11.25% Notes, and the subsidiary guarantors, the non-guarantor subsidiary, certain reclassifications and eliminations and the consolidated Company as of September 30, 2007 and December 31, 2006 and for the three and nine months ended September 30, 2007 and 2006, are as follows:

Consolidated Balance Sheet

	As of September 30, 2007
	Parent and Guarantor Subsidiaries			Non- Guarantor Subsidiary		Reclassifications and Eliminations			Total Consolidated
	(in thousands)
Assets
Current assets:
Cash and cash equivalents	$	19,807		$	—	$	—		$	19,807
Accounts receivable, net		227,815			—		—			227,815
Prepaid expenses and other current assets		16,421			31,018		(29,912	)		17,527
Receivables under insurance programs		24,644			—		—			24,644
Total current assets		288,687			31,018		(29,912	)		289,793
Investments of insurance subsidiary		—			69,264		—			69,264
Property and equipment, net		25,821			—		—			25,821
Other intangibles, net		28,796			—		—			28,796
Goodwill		148,361			—		—			148,361
Deferred income taxes		70,810			—		3,892			74,702
Receivables under insurance programs		30,361			—		—			30,361
Investments in subsidiaries		12,986			—		(12,986	)		—
Other		29,204			229		—			29,433
	$	635,026		$	100,511	$	(39,006	)	$	696,531
Liabilities and members’ equity (deficit)
Current liabilities:
Accounts payable	$	10,247		$	938	$	—		$	11,185
Accrued compensation and physician payable		97,919			—		—			97,919
Other accrued liabilities		46,717			58,278		(26,020	)		78,975
Income taxes payable		2,335			1,104		—			3,439
Current maturities of long-term debt		4,250			—		—			4,250
Deferred income taxes		28,117			36		—			28,153
Total current liabilities		189,585			60,356		(26,020	)		223,921
Long-term debt, less current maturities		628,312			—		—			628,312
Other non-current liabilities		143,384			27,169		—			170,553
Common stock		—			120		(120	)		—
Additional paid in capital		—			4,610		(4,610	)		—
Retained earnings		—			8,001		(8,001	)		—
Accumulated other comprehensive gain		—			255		—			255
Members’ deficit		(326,255	)		—		(255	)		(326,510	)
	$	635,026		$	100,511	$	(39,006	)	$	696,531

16

Consolidated Balance Sheet

	As of December 31, 2006
	Parent and Guarantor Subsidiaries			Non-Guarantor Subsidiary			Reclassifications and Eliminations			Total Consolidated
	(in thousands)
Assets
Current assets:
Cash and cash equivalents	$	3,999		$	—		$	—		$	3,999
Accounts receivable, net		207,031			—			—			207,031
Prepaid expenses and other current assets		10,690			22,776			(22,003	)		11,463
Receivables under insured programs		36,287			—			—			36,287
Income tax receivable		1,452			—			(49	)		1,403
Total current assets		259,459			22,776			(22,052	)		260,183
Investments of insurance subsidiary		—			59,809			—			59,809
Property and equipment, net		21,847			—			—			21,847
Other intangibles, net		29,051			—			—			29,051
Goodwill		150,459			—			—			150,459
Deferred income taxes		81,335			180			5,211			86,726
Receivables under insured programs		23,213			—			—			23,213
Investment in subsidiary		12,771			—			(12,771	)		—
Other		23,071			201			—			23,272
	$	601,206		$	82,966		$	(29,612	)	$	654,560
Liabilities and members’ equity (deficit)
Current liabilities:
Accounts payable	$	13,584		$	34		$	—		$	13,618
Accrued compensation and physician payable		86,410			—			—			86,410
Other accrued liabilities		53,658			39,989			(16,792	)		76,855
Income taxes payable		—			49			(49	)		—
Current maturities of long-term debt		11,050			—			—			11,050
Deferred income taxes		22,673			—			—			22,673
Total current liabilities		187,375			40,072			(16,841	)		210,606
Long-term debt, less current maturities		631,500			—			—			631,500
Other non-current liabilities		149,021			30,123			—			179,144
Common shares		—			120			(120	)		—
Additional paid in capital		—			4,610			(4,610	)		—
Retained earnings		—			8,313			(8,313	)		—
Accumulated other comprehensive loss		(4	)		(272	)		—			(276	)
Members’ deficit		(366,686	)		—			272			(366,414	)
	$	601,206		$	82,966		$	(29,612	)	$	654,560

17

Consolidated Statement of Operations

	Three Months Ended September 30, 2007
	Parent and Guarantor Subsidiaries			Non-Guarantor Subsidiary			Reclassifications and Eliminations			Total Consolidated
	(in thousands)
Net revenue	$	550,949		$	9,757		$	(9,757	)	$	550,949
Provision for uncollectibles		236,345			—			—			236,345
Net revenues less provision for uncollectibles		314,604			9,757			(9,757	)		314,604
Cost of services rendered
Professional expenses		246,274			5,935			(9,757	)		242,452
Gross profit		68,330			3,822			—			72,152
General and administrative expenses		28,429			67			—			28,496
Management fee and other expenses		1,217			—			—			1,217
Depreciation and amortization		3,868			—			—			3,868
Interest expense (income), net		14,483			(844	)		—			13,639
Earnings from continuing operations before income taxes		20,333			4,599			—			24,932
Provision for income taxes		7,742			1,610			—			9,352
Earnings from continuing operations		12,591			2,989			—			15,580
Loss from discontinued operations net of taxes		(152	)		—			—			(152	)
Net earnings	$	12,439		$	2,989		$	—		$	15,428

Consolidated Statement of Operations

	Three Months Ended September 30, 2006
	Parent and Guarantor Subsidiaries		Non-Guarantor Subsidiary			Reclassifications and Eliminations			Total Consolidated
	(in thousands)
Net revenue	$	481,033	$	10,075		$	(10,075	)	$	481,033
Provision for uncollectibles		197,749		—			—			197,749
Net revenue less provision for uncollectibles		283,284		10,075			(10,075	)		283,284
Cost of services rendered
Professional expenses		232,266		6,127			(10,075	)		228,318
Gross profit		51,018		3,948			—			54,966
General and administrative expenses		26,093		50			—			26,143
Management fee and other expenses		877		—			—			877
Depreciation and amortization		6,109		—			—			6,109
Interest (income) expense, net		15,724		(519	)		—			15,205
Earnings from continuing operations before income taxes		2,215		4,417			—			6,632
Provision for income taxes		1,859		376			—			2,235
Earnings from continuing operations		356		4,041			—			4,397
Earnings from discontinued operations		105		—			—			105
Net earnings	$	461	$	4,041		$	—		$	4,502

18

Consolidated Statement of Operations

	Nine Months Ended September 30, 2007
	Parent and Guarantor Subsidiaries			Non-Guarantor Subsidiary			Reclassifications and Eliminations			Total Consolidated
	(in thousands)
Net revenue	$	1,555,082		$	29,802		$	(29,802	)	$	1,555,082
Provision for uncollectibles		636,570			—			—			636,570
Net revenues less provision for uncollectibles		918,512			29,802			(29,802	)		918,512
Cost of services rendered
Professional expenses		731,432			9,048			(29,802	)		710,678
Gross profit		187,080			20,754			—			207,834
General and administrative expenses		83,103			207			—			83,310
Management fee and other expenses		3,035			—			—			3,035
Depreciation and amortization		10,956			—			—			10,956
Interest expense (income), net		43,760			(2,330	)		—			41,430
Earnings from continuing operations before income taxes		46,226			22,877			—			69,103
Provision for income taxes		18,545			8,007			—			26,552
Earnings from continuing operations		27,681			14,870			—			42,551
Loss from discontinued operations net of taxes		(499	)		—			—			(499	)
Net earnings	$	27,182		$	14,870		$	—		$	42,052

Consolidated Statement of Operations

	Nine months ended September 30, 2006
	Parent and Guarantor Subsidiaries			Non-Guarantor Subsidiary			Reclassifications and Eliminations			Total Consolidated
	(in thousands)
Net revenue	$	1,346,624		$	27,275		$	(27,275	)	$	1,346,624
Provision for uncollectibles		537,980			—			—			537,980
Net revenue less provision for uncollectibles		808,644			27,275			(27,275	)		808,644
Cost of services rendered
Professional expenses		661,068			4,040			(27,275	)		637,833
Gross profit		147,576			23,235			—			170,811
General and administrative expenses		74,851			135			—			74,986
Management fee and other expenses		2,690			—			—			2,690
Depreciation and amortization		19,879			—			—			19,879
Interest (income) expense, net		44,569			(1,452	)		—			43,117
Earnings from continuing operations before income taxes		5,587			24,552			—			30,139
Provision for income taxes		4,375			7,225			—			11,600
Earnings from continuing operations		1,212			17,327			—			18,539
Loss from discontinued operations		(6,904	)		—			—			(6,904	)
Net earnings (loss)	$	(5,692	)	$	17,327		$	—		$	11,635

19

Consolidated Statement of Cash Flows

	Nine Months Ended September 30, 2007
	Parent and Guarantor Subsidiaries			Non-Guarantor Subsidiary			Reclassifications and Eliminations		Total Consolidated
	(in thousands)
Operating activities
Net earnings	$	27,182		$	14,870		$	—	$	42,052
Adjustments to reconcile net earnings:
Depreciation and amortization		10,994			—			—		10,994
Amortization of deferred financing costs		1,615			—			—		1,615
Employee based compensation expense		419			—			—		419
Provision for uncollectibles		636,570			—			—		636,570
Deferred income taxes		18,092			1,349			—		19,441
Loss on sale of equipment		407			—			—		407
Equity in joint venture income		(1,360	)		—			—		(1,360	)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable		(657,354	)		—			—		(657,354	)
Prepaids and other assets		(2,513	)		(9,588	)		—		(12,101	)
Income tax accounts		3,153			1,054			—		4,207
Accounts payable		(1,347	)		(1,086	)		—		(2,433	)
Accrued compensation and physician payable		12,979			—			—		12,979
Other accrued liabilities		(3,540	)		9,257			—		5,717
Professional liability reserves		(16,772	)		6,079			—		(10,693	)
Net cash provided by operating activities		28,525			21,935			—		50,460
Investing activities
Purchases of property and equipment		(10,865	)		—			—		(10,865	)
Cash paid for acquisitions, net		(3,545	)		—			—		(3,545	)
Net purchases of investments by insurance subsidiary		—			(8,925	)		—		(8,925	)
Other investing activities		125			—			—		125
Net cash used in investing activities		(14,285	)		(8,925	)		—		(23,210	)
Financing activities
Payments on notes payable		(3,188	)		—			—		(3,188	)
Proceeds from revolving credit facility		83,000			—			—		83,000
Payments on revolving credit facility		(89,800	)		—			—		(89,800	)
Payments of deferred financing costs		(500	)		—			—		(500	)
Redemption of common units		(1,004	)		—			—		(1,004	)
Proceeds from sales of common units		50			—			—		50
Net transfers from parent and parent’s subsidiaries		13,010			(13,010	)		—		—
Net cash provided by (used in) financing activities		1,568			(13,010	)		—		(11,442	)
Net increase in cash and cash equivalents		15,808			—			—		15,808
Cash and cash equivalents, beginning of period		3,999			—			—		3,999
Cash and cash equivalents, end of period	$	19,807		$	—		$	—	$	19,807

20

Consolidated Statement of Cash Flows

	Nine months ended September 30, 2006
	Parent and Guarantor Subsidiaries			Non-Guarantor Subsidiary			Reclassifications and Eliminations		Total Consolidated
	(in thousands)
Operating activities
Net earnings (loss)	$	(5,692	)	$	17,327		$	—	$	11,635
Adjustments to reconcile net earnings (loss):
Depreciation and amortization		20,462			—			—		20,462
Amortization of deferred financing costs		1,821			—			—		1,821
Employee equity based compensation expense		477			—			—		477
Provision for uncollectibles		537,980			—			—		537,980
Impairment of intangibles		9,523			—			—		9,523
Deferred income taxes		(1,447	)		(1,114	)		—		(2,561	)
Loss on sale of equipment		23			—			—		23
Equity in joint venture income		(1,502	)		—			—		(1,502	)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable		(552,012	)		—			—		(552,012	)
Prepaids and other assets		(2,293	)		(10,815	)		—		(13,108	)
Income tax accounts		15,871			1,655			—		17,526
Accounts payable		(9,083	)		(12	)		—		(9,095	)
Accrued compensation and physician payable		987			—			—		987
Other accrued liabilities		(8,143	)		13,043			—		4,900
Professional liability reserves		1,893			2,556			—		4,449
Net cash provided by operating activities		8,865			22,640			—		31,505
Investing activities
Purchases of property and equipment		(7,173	)		—			—		(7,173	)
Cash paid for acquisitions, net		(20,785	)		—			—		(20,785	)
Net purchases of investments by insurance subsidiary		—			(12,640	)		—		(12,640	)
Other investing activities		209			—			—		209
Net cash used in investing activities		(27,749	)		(12,640	)		—		(40,389	)
Financing activities
Payments on notes payable		(3,187	)		—			—		(3,187	)
Proceeds from revolving credit facility		184,300			—			—		184,300
Payment on revolving credit facility		(176,700	)		—			—		(176,700	)
Payment of deferred financing costs		(752	)		—			—		(752	)
Purchase of treasury stock		(2,570	)		—			—		(2,570	)
Transaction payments in connection with recapitalization		(56	)		—			—		(56	)
Proceeds from sale of common units		115			—			—		115
Net transfers from parent and parent’s subsidiaries		10,000			(10,000	)		—		—
Net cash provided by (used in) financing activities		11,150			(10,000	)		—		1,150
Decrease in cash and cash equivalents		(7,734	)		—			—		(7,734	)
Cash and cash equivalents, beginning of period		10,644			—			—		10,644
Cash and cash equivalents, end of period	$	2,910		$	—		$	—	$	2,910

21

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Introduction

We believe we are the largest national provider of outsourced physician staffing and administrative services to hospitals and other healthcare providers in the United States based on revenues and patient visits. Our regional operating models also include comprehensive programs for inpatient care, radiology, pediatrics and other healthcare services, principally within hospital departments and other healthcare treatment facilities. We have, however, focused primarily on providing outsourced services to hospital emergency departments, which accounts for the majority of our revenue.

The following discussion provides an assessment of our results of operations, liquidity and capital resources and should be read in conjunction with our consolidated financial statements and notes thereto included elsewhere in this document.

Critical Accounting Policies and Estimates

The consolidated financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States, which requires us to make estimates and assumptions. Management believes the following critical accounting policies, among others, affect its more significant judgments and estimates used in the preparation of its consolidated financial statements.

There have been no changes to these critical accounting policies or their application during the nine months ended September 30, 2007.

Revenue Recognition

Net Revenue. Net revenues consist of fee-for-service revenue, contract revenue and other revenue. Net revenues are recorded in the period services are rendered. Our net revenues are principally derived from the provision of healthcare staffing services to patients within healthcare facilities. The form of billing and related risk of collection for such services may vary by customer. The following is a summary of the principal forms of our billing arrangements and how net revenue is recognized for each.

A significant portion (79% and 78% of our net revenue in the nine months ended September 30, 2007 and the year ended December 31, 2006, respectively) resulted from fee-for-service patient visits. Fee-for-service revenue represents revenue earned under contracts in which we bill and collect the professional component of charges for medical services rendered by our contracted and employed physicians. Under the fee-for-service arrangements, we bill patients for services provided and receive payment from patients or their third-party payers. Fee-for-service revenue is reported net of contractual allowances and policy discounts. All services provided are expected to result in cash flows and are therefore reflected as net revenues in the financial statements. Fee-for-service revenue is recognized in the period that the services are rendered to specific patients and reduced immediately for the estimated impact of contractual allowances in the case of those patients having third-party payer coverage. The recognition of net revenue (gross charges less contractual allowances) from such visits is dependent on such factors as proper completion of medical charts following a patient visit, the forwarding of such charts to one of our billing centers for medical coding and entering into our billing systems and the verification of each patient’s submission or representation at the time services are rendered as to the payer(s) responsible for payment of such services. Net revenues are recorded based on the information known at the time of entering of such information into our billing systems as well as an estimate of the net revenues associated with medical charts for a given service period that have not been processed yet into our billing systems. The above factors and estimates are subject to change. For example, patient payer information may change following an initial attempt to bill for services due to a change in payer status. Such changes in payer status have an impact on recorded net revenue due to differing payers being subject to different contractual allowance amounts. Such changes in net revenue are recognized in the period that such changes in payer become

22

known. Similarly, the actual volume of medical charts not processed into our billing systems may be different from the amounts estimated. Such differences in net revenue are adjusted in the following month based on actual chart volumes processed.

Contract revenue represents revenue generated under contracts in which we provide physician and other healthcare staffing and administrative services in return for a contractually negotiated fee. Contract revenue consists primarily of billings based on hours of healthcare staffing provided at agreed to hourly rates. Revenue in such cases is recognized as the hours are worked by our staff and contractors. Additionally, contract revenue also includes supplemental revenue from hospitals where we may have a fee-for-service contract arrangement. Contract revenue for the supplemental billing in such cases is recognized based on the terms of each individual contract. Such contract terms generally either provide for a fixed monthly dollar amount or a variable amount based upon measurable monthly activity, such as hours staffed, patient visits or collections per visit compared to a minimum activity threshold. Such supplemental revenues based on variable arrangements are usually contractually fixed on a monthly, quarterly or annual calculation basis considering the variable factors negotiated in each such arrangement. Such supplemental revenues are recognized as revenue in the period when such amounts are determined to be fixed and therefore contractually obligated as payable by the customer under the terms of the respective agreement.

Other revenue consists primarily of revenue from management and billing services provided to outside parties. Revenue is recognized for such services pursuant to the terms of the contracts with customers. Generally, such contracts consist of fixed monthly amounts with revenue recognized in the month services are rendered or as hourly consulting fees recognized as revenue as hours are worked in accordance with such arrangements. Additionally, we derive a small percentage of our revenues from providing billing services that are contingent upon the collection of third-party physician billings by us on their behalf. Such revenues are not considered earned and therefore not recognized as revenue until actual cash collections are achieved in accordance with the contractual arrangements for such services.

Net Revenue Less Provision for Uncollectibles. Net revenue less provision for uncollectibles reflects management’s estimate of billed amounts to ultimately be collected. Management, in estimating the amounts to be collected resulting from its over six million annual fee-for-service patient visits and procedures, considers such factors as prior contract collection experience, current period changes in payer mix and patient acuity indicators, reimbursement rate trends in governmental and private sector insurance programs, resolution of credit balances, the estimated impact of billing system effectiveness improvement initiatives and trends in collections from self-pay patients. Such estimates are substantially formulaic in nature. The estimates are continuously updated and adjusted if subsequent actual collection experience indicates a change in estimate is necessary. Such provisions and any subsequent changes in estimates may result in adjustments to our operating results with a corresponding adjustment to our accounts receivable allowance for uncollectibles on our balance sheet.

Accounts Receivable. As described above and below, we determine the estimated value of our accounts receivable based on estimated cash collection run rates of estimated future collections by contract for patient visits under our fee-for-service contract revenue. Accordingly, we are unable to report the payer mix composition on a dollar basis of our outstanding net accounts receivable. Our days revenue outstanding at September 30, 2007 and at December 31, 2006, were 68.4 days and 67.6 days, respectively. The number of days outstanding will fluctuate over time due to a number of factors. The increase in average days revenue outstanding of approximately 0.8 days includes an increase of 8.0 days associated with an increased valuation of fee-for-service accounts receivable. This increase was partially offset by a decrease of 6.0 days resulting from an increase in average revenue per day between periods and a decrease of 1.2 days related to contract accounts receivable. The increase in average revenue per day is primarily attributable to an increase in gross charges, an increase in Medicare physician reimbursement, increased pricing with managed care plans, and an increase in the average patient acuity, while the increased valuation of fee-for-service accounts receivable is due primarily to new contract start-ups. The decrease of 1.2 days related to contract accounts receivable is due primarily to increased cash collections. Our allowance for doubtful accounts totaled $166.5 million as of September 30, 2007.

23

Approximately 98% of our allowance for doubtful accounts is related to gross fees for fee-for-service patient visits. Our principal exposure for uncollectible fee-for-service visits is centered in self-pay patients and, to a lesser extent, for co-payments and deductibles from patients with insurance. While we do not specifically allocate the allowance for doubtful accounts to individual accounts or specific payer classifications, the portion of the allowance associated with fee-for-service charges as of September 30, 2007, was equal to approximately 90% of outstanding self-pay fee-for-service patient accounts.

The majority of our fee-for-service patient visits are for the provision of emergency care in hospital settings. Due to federal government regulations governing the providing of such care, we are obligated to provide emergency care regardless of the patient’s ability to pay or whether or not the patient has insurance or other third-party coverage for the cost of the services rendered. While we attempt to obtain all relevant billing information at the time emergency care services are rendered, there are numerous patient encounters where such information is not available at time of discharge. In such cases where detailed billing information relative to insurance or other third-party coverage is not available at discharge, we attempt to obtain such information from the patient or client hospital billing record information subsequent to discharge to facilitate the collections process. Collections at the time of rendering such services (emergency room discharge) are not significant. Primary responsibility for collection of fee-for-service accounts receivable resides within our internal billing operations. Once a claim has been submitted to a payer or an individual patient, employees within our billing operations have responsibility for the follow up collection efforts. The protocol for follow up differs by payer classification. For self-pay patients, our billing system will automatically send a series of dunning letters on a prescribed time frame requesting payment or the provision of information reflecting that the balance due is covered by another payer, such as Medicare or a third-party insurance plan. Generally, the dunning cycle on a self pay account will run from 90 to 120 days. At the end of this period, if no collections or additional information is obtained from the patient, the account is no longer considered an active account and is transferred to a collection agency. Upon transfer to a collection agency, the patient account is written-off as a bad debt. Any subsequent cash receipts on accounts previously written off are recorded as a recovery. For non-self pay accounts, billing personnel will follow up and respond to any communication from payers such as requests for additional information or denials until collection of the account is obtained or other resolution has occurred. For contract accounts receivable, invoices for services are prepared in the various operating areas of the Company and mailed to our customers, generally on a monthly basis. Contract terms under such arrangements generally require payment within thirty days of receipt of the invoice. Outstanding invoices are periodically reviewed and operations personnel with responsibility for the customer relationship will contact the customer to follow up on any delinquent invoices. Contract accounts receivable will be considered as bad debt and written-off based upon the individual circumstances of the customer situation after all collection efforts have been exhausted, including legal action if warranted, and it is the judgment of management that the account is not expected to be collected.

Methodology for Computing Allowance for Doubtful Accounts. We employ several methodologies for determining our allowance for doubtful accounts depending on the nature of the net revenue recognized. We initially determine gross revenue for our fee-for-service patient visits based upon established fee schedule prices. Such gross revenue is reduced for estimated contractual allowances for those patient visits covered by contractual insurance arrangements to result in net revenue. Net revenue is then reduced for our estimate of uncollectible amounts. Fee-for-service net revenue less provision for uncollectibles represents our estimated cash to be collected from such patient visits and is net of our estimate of account balances estimated to be uncollectible. The provision for uncollectible fee-for-service patient visits is based on historical experience resulting from the over six million annual patient visits. The significant volume of annual patient visits and the terms of thousands of commercial and managed care contracts and the various reimbursement policies relating to governmental healthcare programs do not make it feasible to evaluate fee-for-service accounts receivable on a specific account basis. Fee-for-service accounts receivable collection estimates are reviewed on a quarterly basis for each of our fee-for-service contracts by period of accounts receivable origination. Such reviews include the use of historical cash collection percentages by contract adjusted for the lapse of time since the date of the patient visit. In addition, when actual collection percentages differ from expected results, on a contract by contract basis supplemental detailed reviews of the outstanding accounts receivable balances may be performed by our billing operations to determine whether there are facts and

24

circumstances existing that may cause a different conclusion as to the estimate of the collectibility of that contract’s accounts receivable from the estimate resulting from using the historical collection experience. Contract-related net revenues are billed based on the terms of the contract at amounts expected to be collected. Such billings are typically submitted on a monthly basis and aged trial balances prepared. Allowances for estimated uncollectible amounts related to such contract billings are made based upon specific accounts and invoice periodic reviews once it is concluded that such amounts are not likely to be collected. The methodologies employed to compute allowances for doubtful accounts were unchanged between 2007 and 2006.

Insurance Reserves. The nature of our business is such that it is subject to professional liability lawsuits. Historically, to mitigate a portion of this risk, we have maintained insurance for individual professional liability claims with per incident and annual aggregate limits per physician for all incidents. Prior to March 12, 2003, we obtained such insurance coverage from a commercial insurance provider. Professional liability claims and lawsuits are routinely reviewed by our insurance carrier and management for purposes of establishing ultimate loss estimates. Provisions for estimated losses in excess of insurance limits have been provided at the time such determinations are made. In addition, where as a condition of a professional liability insurance policy the policy includes a self-insured risk retention layer of coverage, we have recorded a provision for estimated losses likely to be incurred during such periods and within such limits based on our past loss experience following consultation with our outside insurance experts and claims managers.

Subsequent to March 11, 2003, we have provided for a significant portion of our professional liability loss exposures through the use of a captive insurance company and through greater utilization of self-insurance reserves. Since March 12, 2003, our professional liability costs consist of annual projected costs resulting from periodic actuarial studies along with the cost of certain professional liability commercial insurance premiums and programs available to us. An independent actuary firm is responsible for preparation of the periodic actuarial studies. Management’s estimate of our professional liability costs resulting from such actuarial studies is significantly influenced by assumptions, which are limited by the uncertainty of predicting future events, and assessments regarding expectations of several factors. These factors include, but are not limited to: hours of exposure as measured by hours of physician and related professional staff services as well as actual loss development trends; the frequency and severity of claims, which can differ significantly by jurisdiction; coverage limits of third-party insurance; the effectiveness of our claims management process; and the outcome of litigation.

Our commercial insurance policy for professional liability losses for the period March 12, 1999 through March 11, 2003, included insured limits applicable to such coverage in the period. Effective April 2006, we executed an agreement with the commercial insurance provider that issued the policy that ended March 11, 2003 to increase the existing $130.0 million aggregate limit of coverage. Under the terms of the agreement, we will make periodic premium payments to the commercial insurance company and the total aggregate limit of coverage under the policy will be increased by a portion of the premiums paid. We have committed to fund premiums such that the total aggregate limit of coverage under the program remains greater than the paid losses at any point in time. During fiscal year 2006, we funded a total of $11.0 million under this agreement. For the nine months ended September 30, 2007 we funded a total of $6.0 million under this agreement and have agreed to fund an additional $3.6 million in the fourth quarter of 2007. We have the option to fund additional payments in subsequent fiscal years which will be based upon the level of incurred losses relative to the aggregate limit of coverage. As of September 30, 2007, the current aggregate limit of coverage under this policy is $146.0 million and the estimated loss reserve for claim losses and expenses in excess of the current aggregate limit recorded by the Company was $22.9 million.

Our provisions for losses under the aggregate loss limits of our policy in effect prior to March 12, 2003, and under our captive insurance and self-insurance programs since March 12, 2003, are subject to periodic actuarial re-evaluation. The results of such periodic actuarial studies may result in either upward or downward adjustment to our previous loss estimates. The Company’s estimated loss reserves under such programs are discounted at 4.6%.

The accounts of the captive insurance company are fully consolidated with those of our other operations in the accompanying financial statements.

25

Impairment of Intangible Assets

In assessing the recoverability of the Company’s intangibles, we must make assumptions regarding estimated future cash flows and other factors to determine the fair value of the respective assets. If these estimates or their related assumptions change in the future, we may be required to record impairment charges for these assets.

Factors and Trends that Affect Our Results of Operations

In reading our financial statements, you should be aware of the following factors and trends that we believe are important in understanding our financial performance.

2008 Proposed Medicare Fee Schedule Change

On November 1, 2007, the Centers for Medicare & Medicaid Services (“CMS”) announced proposed changes to the Medicare physician fee schedule methodology. The proposed changes would decrease emergency physician payments by a total of 12.1% starting on January 1, 2008.

Of the 12.1% decrease in reimbursement, a 2% decrease would result from proposed changes in the Practice Expense Relative Value Units (“RVU”) for Evaluation and Management codes associated with emergency physicians. Evaluation and Management services are those which reflect time and effort that physicians spend with patients in assessing their condition and are the primary type of code billed in Emergency Medicine. The proposed changes would apply to payments for services furnished to Medicare beneficiaries beginning in 2008. CMS is required to impose a budget neutrality adjustment if changes in RVUs will cause an increase or decrease in overall fee schedule outlays in excess of certain thresholds. In addition to the proposed changes in the RVU values, CMS announced a proposed reduction in the Medicare Conversion Factor (“Conversion Factor”) applicable to all Medicare physician fee payments in the amount of 10.1% for 2008, a reduction required by a statutory formula. There are several bills currently proposed in the U.S. Congress to revise such a result to eliminate the proposed 12.1% rate decrease. However, management cannot predict the outcome of such bills in mitigating the current planned rate decrease. In the event that the total 12.1% rate reduction becomes effective in 2008, we estimate that it will negatively affect our revenues from Medicare and other revenue sources whose rates are linked to changes in the Medicare fee schedule rates by an estimated $23.9 million. Additional changes in managed care revenues are possible if fee schedules maintained by certain of such organizations are revised based on the Medicare fee schedule changes.

Partially offsetting these emergency physician payment reductions is the available participation in a voluntary reporting program for physicians and other healthcare practitioners, whereby eligible professionals who report specific measures on quality of care furnished to Medicare beneficiaries may earn incentives up to 1.5% of their total allowed charges, subject to a cap. We estimate that participation in this program will increase our revenues in 2008 by an estimated $2.7 million.

2008 Allowable Billing Changes

In October 2007, the CPT Advisory Panel of the American Medical Association released a change in how certain emergency department physician services can be billed beginning January 1, 2008. The result of this change decreases the allowable amounts that can be billed for intravenous infusion of medications and rehydration treatment services rendered by the physician within a facility setting. We estimate that the impact from these changes will negatively affect our revenues by an estimated $4.7 million in fiscal year 2008.

Military Healthcare Staffing

We are a provider of healthcare professionals that serve military personnel and their dependents in military treatment facilities nationwide administered by the Department of Defense. Our revenues derived from military healthcare staffing totaled approximately $106.0 million in the first nine months of 2007 compared to approximately $121.1 million in the same period in 2006.

26

Approximately $57.0 million of estimated annual revenue won by us as part of the military’s contract bidding process in 2006 was awarded to us on a one-year contract basis and was subject to re-bid and award on or about October 1, 2007. Approximately $98.1 million of estimated annual revenue won during the bidding process in 2006 was awarded to us on a two—five option year contract basis which gave the government the option to exercise available option years each October 1. The government reserves a portion of its contracts for award to small businesses. We participate in such small business awards to the extent we can serve as a sub-contractor to small businesses that win such bids. Approximately 25.6% of our military staffing revenue for the nine months ended September 30, 2007 is derived through a subcontracting agreement with a small business prime contractor compared to 27.9% for the same period in 2006.

The Company was successful in retaining existing business or winning new bid awards following completion of the bidding process as of October 1, 2007, in the estimated annual amount of $164.6 million. Approximately $90.0 million of annual revenue derived from contracts presently held by other staffing providers or new government contract staffing opportunities were available for bid and awarded prior to October 1, 2007. The estimated amount recently awarded to us of $164.6 million included $43.1 million awarded under one-year contracts.

Anesthesiology related services

In January 2007, we completed a strategic review of our anesthesia management services business, and based upon our review concluded that the existing business model of providing management services to independent physician groups was not a viable long term strategy and could not consistently meet our internal growth targets. As a result of this review, we elected to exit this non-core business line. The final phase of this business line disposal was substantially completed during the third quarter of 2007, therefore under the provisions of Statement of Financial Accounting Standards (SFAS) No. 144, “Accounting for the Impairment of or Disposal of Long Lived Assets”, we have reported the results of the anesthesia operations as discontinued operations for all periods presented.

Results of Operations

The following discussion provides an analysis of our results of operations and should be read in conjunction with our unaudited consolidated financial statements. The operating results of the periods presented were not significantly affected by general inflation in the U.S. economy. Net revenue less the provision for uncollectibles is an estimate of future cash collections and as such it is a key measurement by which management evaluates performance of individual contracts as well as the Company as a whole. The following table sets forth the components of net earnings as a percentage of net revenue less provision for uncollectibles for the periods indicated:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2007		2006		2007		2006
Net revenue less provision for uncollectibles	100.0	%	100.0	%	100.0	%	100.0	%
Professional service expenses	76.7		76.1		76.6		75.8
Professional liability costs	0.3		4.5		0.8		3.0
Gross profit	22.9		19.4		22.6		21.1
General and administrative expenses	9.1		9.2		9.1		9.3
Management fee and other expenses	0.4		0.3		0.3		0.3
Depreciation and amortization	1.2		2.2		1.2		2.5
Interest expense, net	4.3		5.4		4.5		5.3
Earnings from continuing operations before income taxes	7.9		2.3		7.5		3.7
Provision for income taxes	3.0		0.8		2.9		1.4
Earnings from continuing	5.0		1.6		4.6		2.3
Earnings (loss) from discontinued operations, net of taxes	0.0		0.0		(0.1	)	(0.9	)
Net earnings	4.9		1.6		4.6		1.4

27

Three Months Ended September 30, 2007 Compared to the Three Months Ended September 30, 2006

Net Revenue. Net revenue in the three months ended September 30, 2007 increased $69.9 million or 14.5%, to $550.9 million from $481.0 million in the three months ended September 30, 2006. The increase in net revenues of $69.9 million resulted primarily from increases in fee-for-service revenue of $70.2 million and contract revenue of $1.7 million. These increases were slightly offset by a $1.9 million decrease in other revenue. In the three months ended September 30, 2007, fee-for-service revenue was 80.6% of net revenue compared to 77.7% in 2006, contract revenue was 18.3% of net revenue in 2007 compared to 20.6% in 2006 and other revenue was 1.1% in 2007 compared to 1.6% in 2006. The decrease in other revenue is due to the $2.1 million favorable settlement of a lawsuit involving a terminated staffing contract arrangement in the three months ended September 30, 2006.

Provision for Uncollectibles. The provision for uncollectibles was $236.3 million in the three months ended September 30, 2007 compared to $197.7 million in the corresponding period in 2006, an increase of $38.6 million or 19.5%. The provision for uncollectibles as a percentage of net revenue was 42.9% in 2007 compared with 41.1% in 2006. The provision for uncollectibles is primarily related to revenue generated under fee-for-service contracts that is not expected to be fully collected. The period over period increase in the provision is due to a combination of increases in the total billed patient volume, annual increases in gross fee schedules and an increase in self pay gross accounts receivable relative to other payer types. For the three months ended September 30, 2007 self pay fee-for-service patient visits were approximately 23.8% of total fee-for-service patient visits compared to approximately 22.5% in the same period of 2006.

Net Revenue Less Provision for Uncollectibles. Net revenue less provision for uncollectibles in the three months ended September 30, 2007 increased $31.3 million, or 11.1%, to $314.6 million from $283.3 million in the three months ended September 30, 2006. Same contract revenues, which consists of contracts under management in both periods, increased $16.6 million, or 6.8%, to $260.2 million in 2007 compared to $243.7 million in 2006. The increase in same contract revenue of 6.8% consists primarily of increases in patient dollar volume between periods which contributed 1.9% of the growth, an increase in our estimated net revenue per billing unit of 3.5% and an increase of 0.4% associated with a change in prior year revenue estimates. The increase in estimated collections per billing unit is associated primarily with annual increases in gross charges, managed care and Medicare pricing improvements, increased patient acuity, and improvements in realized cash collections, offset by an unfavorable shift in payer mix reflecting an increase in the percentage of self pay volume between periods. Also contributing to the increase is a 0.4% increase associated with a net increase in settlements with managed care plans between periods. Contract and other revenue contributed approximately 0.6% of the increase. The remainder of the increase in revenue less provision for uncollectibles between periods is due to new contracts obtained through internal sales of $34.7 million partially offset by $21.1 million of revenue derived from contracts that terminated during the periods. Acquisitions contributed $1.2 million of growth between periods.

Professional Service Expenses. Professional service expenses, which include physician costs, billing and collection expenses, and other professional expenses, totaled $241.4 million in the three months ended September 30, 2007 compared to $215.5 million in the three months ended September 30, 2006, an increase of $25.9 million or 12.0%. The increase of $25.9 million included an increase of approximately $11.2 million which resulted principally from increases in the number of provider hours staffed and the average rates paid per hour of provider service on a same contract basis. Also contributing to the increase in expense was $1.0 million related to our acquisitions and $13.6 million related to new sales net of terminated contracts.

Professional Liability Costs. Professional liability costs were $1.1 million in the three months ended September 30, 2007 compared with $12.8 million in the three months ended September 30, 2006 for a decrease of $11.7 million. Professional liability costs for the three months ended September 30, 2007 include reductions in professional liability reserves relating to prior years resulting from our recent actuarial study completed in October of 2007 of $12.5 million. Excluding the favorable actuarial adjustments, professional liability costs

28

increased $0.7 million between periods primarily due to an increase in provider hours in 2007. The increase in provider hours is predominantly a result of our net growth and, to a lesser extent, increased provider hours staffed on a same contract basis. The reduction in prior professional liability reserves is due to favorable trends in loss estimates primarily associated with improvements in overall frequency of claims reported and favorable changes in loss development assumptions.

Gross Profit. Gross profit was $72.2 million in the three months ended September 30, 2007 compared to $55.0 million in the same period in 2006 for an increase of $17.2 million between periods. Included in the $17.2 million increase is a decrease in professional liability costs between periods of $12.5 million resulting from our actuarial study completed in October 2007. Excluding the impact of the decrease in professional liability costs profit increased $4.7 million. The increase in gross profit, excluding the decrease in professional liability costs, is primarily due to improvements on a same contract basis between periods.

Gross profit as a percentage of revenue less provision for uncollectibles increased to 22.9% in 2007 compared with 19.4% in 2006.

General and Administrative Expenses. General and administrative expenses increased $2.4 million to $28.5 million for the three months ended September 30, 2007 from $26.1 million in the three months ended September 30, 2006. General and administrative expenses as a percentage of net revenue less provision for uncollectibles were 9.1% in 2007 and 9.2% in 2006. The increase in general and administrative expenses of $2.4 million between periods is primarily due to new positions and inflationary growth in salaries and increases in incentive plan and commission costs.

Management Fee and Other Expenses. Management fee and other expenses were $1.2 million and $0.9 million in the three months ended September 30, 2007 and 2006, respectively.

Depreciation and Amortization. Depreciation and amortization was $3.9 million in the three months ended September 30, 2007 compared to $6.1 million for the three months ended September 30, 2006. Depreciation and amortization expense decreased $2.2 million between periods due to a decrease in amortization expense of $2.6 million. The decline in amortization expense was due primarily to contract intangibles being fully amortized during 2007 partially offset by an increase in contract intangibles related to acquisitions that occurred in 2007.

Net Interest Expense. Net interest expense decreased $1.6 million to $13.6 million in the three months ended September 30, 2007, compared to $15.2 million in the corresponding period in 2006 primarily due to the reduction of our interest rate on the term loan as a result of the second quarter 2007 amendment to our senior credit agreement, lower revolver borrowings between periods and an increase in interest income from investments of our insurance subsidiary.

Earnings from Continuing Operations before Income Taxes. Earnings from continuing operations before income taxes in the three months ended September 30, 2007 were $24.9 million compared to $6.6 million in the corresponding period in 2006.

Provision for Income Taxes. The provision for income taxes was $9.4 million in the three months ended September 30, 2007 compared to $2.2 million in the corresponding period in 2006.

Earnings from Continuing Operations. Earnings from continuing operations were $15.6 million compared to $4.4 million in the corresponding period in 2006.

Earnings (loss) from Discontinued Operations, net of taxes. Earnings (loss) from discontinued operations, net of taxes was a loss of $0.2 million for the three months ended September 30, 2007 compared to earnings of $0.1 million in the corresponding period in 2006. Contributing to the loss in 2007 were $0.1 million of severance and other exit costs related to the disposal of the anesthesia business unit.

Net Earnings. Net earnings were $15.4 million in the three months ended September 30, 2007 compared to $4.5 million in the three months ended September 30, 2006.

29

Nine Months Ended September 30, 2007 Compared to the Nine Months Ended September 30, 2006

Net Revenue. Net revenue in the nine months ended September 30, 2007 increased $208.5 million or 15.5%, to $1,555.1 million from $1,346.6 million in the nine months ended September 30, 2006. The increase in net revenues of $208.5 million resulted primarily from increases in fee-for-service revenue of $184.4 million, contract revenue of $23.6 million and other revenue of $0.4 million. In the nine months ended September 30, 2007, fee-for-service revenue was 79.3% of net revenue compared to 77.9% in 2006, contract revenue was 19.5% of net revenue in 2007 compared to 20.8% in 2006 and other revenue was 1.2% in 2007 compared to 1.3% in 2006.

Provision for Uncollectibles. The provision for uncollectibles was $636.6 million in the nine months ended September 30, 2007 compared to $538.0 million in the corresponding period in 2006, an increase of $98.6 million or 18.3%. The provision for uncollectibles as a percentage of net revenue was 40.9% in 2007 compared with 40.0% in 2006. The provision for uncollectibles is primarily related to revenue generated under fee-for-service contracts that is not expected to be fully collected. The period over period increase in the provision is due to a combination of increases in the total billed patient volume, annual increases in gross fee schedules and an increase in self pay gross accounts receivable relative to other payer types. For the nine months ended September 30, 2007 self pay fee-for-service patient visits were approximately 22.5% of total fee-for-service patient visits compared to approximately 21.4% in the same period of 2006.

Net Revenue Less Provision for Uncollectibles. Net revenue less provision for uncollectibles in the nine months ended September 30, 2007 increased $109.9 million, or 13.6%, to $918.5 million from $808.6 million in the nine months ended September 30, 2006. Same contract revenues, which consists of contracts under management in both periods, increased $45.7 million, or 6.7%, to $725.0 million in 2007 compared to $679.3 million in 2006. The increase in same contract revenue of 6.7% consists primarily of increases in patient dollar volume between periods which contributed 2.4% of the growth, an increase in our estimated net revenue per billing unit of 3.5% and an increase of 0.8% associated with a change in prior year revenue estimates. The increase in estimated collections per billing unit is associated primarily with annual increases in gross charges, managed care and Medicare pricing improvements, increased patient acuity, and improvements in realized cash collections, offset by an unfavorable shift in payer mix reflecting an increase in the percentage of self pay volume between periods. Contract and other revenue contributed approximately 0.8% of the increase. These increases were partially offset by a decline of approximately 0.8% associated with a net decline in settlements with managed care plans between periods. The remainder of the increase in revenue less provision for uncollectibles between periods is due to new contracts obtained through internal sales of $93.0 million partially offset by $57.2 million of revenue derived from contracts that terminated during the periods. Acquisitions contributed $28.4 million of growth between periods.

Professional Service Expenses. Professional service expenses, which include physician costs, billing and collection expenses, and other professional expenses, totaled $703.4 million in the nine months ended September 30, 2007 compared to $613.3 million in the nine months ended September 30, 2006, an increase of $90.1 million or 14.7%. The increase of $90.1 million included an increase of approximately $34.4 million which resulted principally from increases in the number of provider hours staffed and the average rates paid per hour of provider service on a same contract basis. Also contributing to the increase in expense was $21.2 million related to our acquisitions and $34.5 million related to new sales net of terminated contracts.

Professional Liability Costs. Professional liability costs were $7.3 million in the nine months ended September 30, 2007 compared with $24.5 million in the nine months ended September 30, 2006 for a decrease of $17.2 million. Professional liability costs include reductions in professional liability reserves relating to prior years resulting from actuarial studies completed in April and October of each year of $32.1 million in 2007 and $12.1 million in 2006. Excluding the favorable actuarial adjustments, professional liability costs increased $2.8 million between periods primarily due to an increase in provider hours in 2007. The increase in provider hours is predominately a result of our net growth and acquisitions and to a lesser extent increased provider hours staffed

30

on a same contract basis. The reduction in prior year professional liability reserves is due to favorable trends in loss estimates primarily associated with improvements in the overall frequency of claims reported and favorable changes in loss development assumptions.

Gross Profit. Gross profit was $207.8 million in the nine months ended September 30, 2007 compared to $170.8 million in the same period in 2006 for an increase of $37.0 million between periods. Included in the $37.0 million increase is a net decrease in professional liability costs between periods of $20.0 million resulting from the actuarial studies completed in April and October of each year. Excluding the impact of the net decrease in professional liability costs gross profit increased $17.0 million. The increase in gross profit, excluding the decrease in professional liability costs, is primarily due to the contribution from our 2007 acquisitions and improvements on a same contract basis between periods.

Gross profit as a percentage of revenue less provision for uncollectibles was 22.6% in 2007 compared to 21.1% in 2006.

General and Administrative Expenses. General and administrative expenses increased $8.3 million to $83.3 million for the nine months ended September 30, 2007 from $75.0 million in the nine months ended September 30, 2006. General and administrative expenses as a percentage of net revenue less provision for uncollectibles were 9.1% in 2007 and 9.3% in 2006. Acquisitions contributed $2.3 million of the increase in general and administrative expenses. The remaining $6.0 million increase in general and administrative expenses in 2007 are increases primarily related to new positions and inflationary growth in salaries and benefits and increases in incentive plan and commission costs.

Management Fee and Other Expenses. Management fee and other expenses were $3.0 million and $2.7 million in the nine months ended September 30, 2007 and 2006, respectively.

Depreciation and Amortization. Depreciation and amortization was $11.0 million in the nine months ended September 30, 2007 compared to $19.9 million for the nine months ended September 30, 2006. Depreciation and amortization expense decreased $8.9 million between periods due to a decrease in amortization expense of $10.0 million. The decline in amortization expense was due primarily to contract intangibles being fully amortized during 2007 partially offset by an increase in contract intangibles related to acquisitions that occurred in 2007 and 2006.

Net Interest Expense. Net interest expense decreased $1.7 million to $41.4 million in the nine months ended September 30, 2007, compared to $43.1 million in the corresponding period in 2006. The decrease in net interest expense is primarily due to an increase in interest income from investments of our insurance subsidiary and a decrease in revolver borrowings between periods.

Earnings From Continuing Operations before Income Taxes. Earnings from continuing operations before income taxes in the nine months ended September 30, 2007 were $69.1 million compared to $30.1 million in the corresponding period in 2006.

Provision for Income Taxes. The provision for income taxes was $26.6 million in the nine months ended September 30, 2007 compared to $11.6 million in the corresponding period in 2006.

Earnings From Continuing Operations. Earnings from continuing operations were $42.6 million in the nine months ended September 30, 2007 compared to $18.5 million in the corresponding period in 2006.

Loss from Discontinued Operations, net of taxes. Loss from discontinued operations, net of taxes was $0.5 million in the nine months ended September 30, 2007 compared to a loss of $6.9 million in the corresponding period in 2006. Contributing to the loss in 2007 were $1.0 million of severance and other exit costs related to the disposal of the anesthesia business unit. The loss in 2006 includes an impairment loss of $9.5 million.

Net Earnings. Net earnings were $42.1 million in the nine months ended September 30, 2007 compared to $11.6 million in the nine months ended September 30, 2006.

31

Liquidity and Capital Resources

Our principal ongoing uses of cash are to meet working capital requirements, fund debt obligations and to finance our capital expenditures and acquisitions. We believe that our cash needs, other than for significant acquisitions, will continue to be met through the use of existing available cash, cash flows derived from future operating results and cash generated from borrowings under our senior secured revolving credit facility.

Cash provided by operating activities in the nine months ended September 30, 2007 was $50.5 million compared to $31.5 million in the corresponding period in 2006. The $19.0 million increase in cash provided by operating activities was principally due to increased earnings and a reduced level of cash funding of accounts payable and other working capital payables between periods offset by an increase in funding of accounts receivable. For the nine months ended September 30, 2007 and 2006 our anesthesia operations had a use of operating cash of $1.3 million and $0.9 million, respectively. Cash used in investing activities in the nine months ended September 30, 2007, was $23.2 million compared to cash used in investing activities of $40.4 million in 2006. The $17.2 million decrease in cash used in investing activities was principally due to a decrease in cash payments made related to acquisitions and a decrease in captive investment purchases between periods partially offset by an increase in capital expenditures. Cash used in financing activities in the nine months ended September 30, 2007 was $11.4 million compared to cash provided by financing activities of $1.2 million in the nine months ended September 30, 2006. The $12.6 million increase in cash used in financing activities was principally due to the net reduction in outstanding amounts under the revolving credit facility between periods.

We spent $10.9 million in the first nine months of 2007 and $7.2 million in the first nine months of 2006 for capital expenditures. These expenditures were primarily for information technology investments and related development projects along with projects in support of operational initiatives.

We are highly leveraged. As of September 30, 2007, we had $632.6 million in aggregate indebtedness, with an additional $125.0 million of borrowing capacity available under our senior secured revolving credit facility (without giving effect to $7.1 million of undrawn letters of credit).

Borrowings outstanding under the senior credit facility mature in various years with a final maturity date of December 1, 2013. The senior credit facility agreement contains both affirmative and negative covenants, including limitations on our ability to incur additional indebtedness, sell material assets, retire, redeem or otherwise reacquire our capital stock, acquire the capital stock or assets of another business, pay dividends, and require the Company to comply with certain coverage and leverage ratios. The senior credit agreement also includes a provision for the prepayment of a portion of the outstanding term loan amounts at any year-end if we generate “excess cash flow”, as defined in the agreement.

Effective April 5, 2007, we amended our senior credit agreement. The amendment reduced the interest rate on any term loans outstanding equal to the euro dollar rate plus 2.00% or the agent bank’s base rate plus 1.00%. Previously, the interest rate on term loan borrowings was equal to the euro dollar rate plus 2.50% or the agent bank’s base rate plus 1.50%. We are subject to an increase in the term loan interest rate in the amount of 0.25% in the event of a downgrade in the corporate family rating of the Company by either Moody’s or Standard and Poor’s rating agencies. In addition, prior to April 5, 2008, in the event of a prepayment of the outstanding term loans associated with a refinancing whose primary purpose is a reduction in the term loan interest rate, we will pay a fee equal to 1.0% of the prepayment amount. Other significant terms and conditions of the credit agreement, including the maturity date of November 23, 2012, did not change under the amendment.

The Company and its subsidiaries, affiliates or significant shareholders (including The Blackstone Group L.P. and its affiliates) may from time to time, in their sole discretion, purchase, repay, redeem or retire any of the Company’s outstanding debt or equity securities (including any publicly issued debt or equity securities), in privately negotiated or open market transactions, by tender offer or otherwise.

32

As of September 30, 2007, we had total cash and cash equivalents of approximately $19.8 million. Our ongoing cash needs for the nine months ended September 30, 2007 were substantially met from internally generated operating sources and periodic borrowings under our revolving credit facility. During the nine months ended September 30, 2007, we borrowed $83.0 million and subsequently repaid $89.8 million under our revolving credit facility. As of September 30, 2007 there were no amounts outstanding under the revolving credit facility.

During the nine months ended September 30, 2007, $3.5 million in cash payments were made related to current year acquisitions and contingent consideration paid on a prior year acquisition. Future contingent payment obligations are approximately $11.8 million as of September 30, 2007.

Effective March 12, 2003, we began providing for professional liability risks in part through a captive insurance company. Prior to such date we insured such risks principally through the commercial insurance market. The change in the professional liability insurance program initially resulted in increased cash flow due to the retention of cash formerly paid out in the form of insurance premiums to a commercial insurance company coupled with a long period (typically 2-4 years or longer on average) before cash payout of such losses occurs. A portion of such cash retained is retained within our captive insurance company and therefore not immediately available for general corporate purposes. As of September 30, 2007, the current value of cash or cash equivalents and related investments held within the captive insurance company totaled approximately $69.3 million. Effective June 1, 2007, we renewed our fronting program with a commercial insurance carrier through May 31, 2008. As part of this renewal, we paid cash premiums associated with the fronting arrangement of approximately $13.3 million. Based upon the results of our most recent actuarial report and insurance program renewal, we anticipate cash funding to the captive insurance subsidiary of approximately $25.1 million. We anticipate such fundings to the captive insurance subsidiary will commence during October 2007 and will continue through May 2008. In addition, for the nine months ended September 30, 2007 we funded a total of $6.0 million and have agreed to fund an additional $3.6 million in the fourth quarter of 2007 to a commercial insurance provider in order to meet our obligation for incurred costs in excess of the aggregate limits of coverage in place on the commercial insurance policy that ended March 11, 2003. We have the option to fund additional premium payments under this program in subsequent fiscal years which will be based upon the level of incurred losses relative to the aggregate limit of coverage at that time.

33

Under the indenture governing the senior subordinated notes, our ability to engage in certain activities such as incurring certain additional indebtedness, making certain investments, and paying certain dividends is tied to ratios based on Adjusted EBITDA (which is defined as “EBITDA” in the indenture). Adjusted EBITDA under the indenture is defined as net earnings before interest expense, taxes, depreciation and amortization, as further adjusted to exclude unusual items, non-cash items and the other adjustments shown in the table below. We believe that the disclosure of the calculation of Adjusted EBITDA provides information that is useful to an investor’s understanding of our liquidity and financial flexibility. EBITDA is not a measurement of financial performance or liquidity under generally accepted accounting principles. It should not be considered in isolation or as a substitute for net income, operating income, cash flows from operating, investing or financing activities, or any other measure calculated in accordance with generally accepted accounting principles. Adjusted EBITDA as calculated under the indenture for the senior subordinated notes is as follows (in thousands):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2007		2006			2007		2006
Net earnings	$	15,428	$	4,502		$	42,052	$	11,635
Loss (earnings) from discontinued operations, net of taxes		152		(105	)		499		6,904
Interest expense, net		13,639		15,205			41,430		43,117
Provision for income taxes		9,352		2,235			26,552		11,600
Depreciation and amortization		3,868		6,109			10,956		19,879
EBITDA		42,439		27,946			121,489		93,135
Management fee and other expenses (a)		1,217		877			3,035		2,690
Restricted unit expense (b)		140		140			417		475
Insurance subsidiary interest income		844		519			2,330		1,452
Severance and other charges		265		281			1,610		490
Adjusted EBITDA*	$	44,905	$	29,763		$	128,881	$	98,242

* Adjusted EBITDA totals include the effects of professional liability loss reserve adjustments of $32,089 and $12,068 for the nine months ended September 30, 2007 and 2006, respectively. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations”.

(a) Reflects management sponsor fee and loss on disposal of assets.

(b) Reflects costs related to the recognition of expense in connection with the issuance of restricted units under the 2005 unit plan.

Inflation

We do not believe that general inflation in the U.S. economy has had a material impact on our financial position or results of operations.

Seasonality

Historically, our revenues and operating results have reflected minimal seasonal variation due to the significance of revenues derived from patient visits to emergency departments, which are generally open on a 365 day basis, and also due to our geographic diversification. Revenue from our non-emergency department staffing lines is dependent on a healthcare facility being open during selected time periods. Revenue in such instances will fluctuate depending upon such factors as the number of holidays in the period.

Recently Issued Accounting Standards

In June 2006, the Financial Accounting Standards Board (“FASB”) issued Interpretation No. 48, “Accounting for Uncertainty in Income Taxes”, an interpretation of FAS109, “Accounting for Income Taxes” (“FIN 48”), to create a single model to address accounting for uncertainty in tax positions. FIN 48 clarifies the

34

accounting for income taxes, by prescribing a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. FIN 48 also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. FIN 48 is effective for fiscal years beginning after December 15, 2006.

The Company adopted the provisions of FIN 48 on January 1, 2007. As a result of the implementation of FIN 48, the Company recognized approximately a $1.6 million charge to members’ equity, a reduction in the deferred tax assets of approximately $0.4 million and an increase in the liability for unrecognized tax benefits of approximately $1.3 million. The Company recognizes interest accrued related to the unrecognized tax benefits in interest expense and penalties in operating expenses. Included in the above estimates is approximately $0.2 million of interest expense.

The amount of unrecognized tax benefits that, if recognized, would affect the effective rate are approximately $1.6 million.

The Company and its subsidiaries file income tax returns in the U. S. federal jurisdiction and various state jurisdictions. With few exceptions, the Company is no longer subject to U. S. federal, state or local examination by tax authorities for years before 2003.

In September 2006, FASB issued Statement of Financial Accounting Standards SFAS No. 157, “Fair Value Measurements,” which provides enhanced guidance for using fair value to measure assets and liabilities. SFAS No. 157 establishes a common definition of fair value, provides a framework for measuring fair value under U.S. GAAP and expands disclosures requirements about fair value measurements. SFAS No. 157 is effective for financial statements issued in fiscal years beginning after November 15, 2007, and interim periods within those fiscal years. The Company is currently evaluating the impact, if any, the adoption of SFAS No. 157 will have on the Company’s financial reporting and disclosures.

In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities—Including an amendment of FASB Statement No. 115 (“SFAS 159”). SFAS 159 permits entities to measure eligible assets and liabilities at fair value. Unrealized gains and losses on items for which the fair value option has been elected are reported in earnings. SFAS 159 is effective for fiscal years beginning after November 15, 2007. The provisions of SFAS 159 will become effective on January 1, 2008, and we have not yet determined the impact, if any, on our consolidated financial statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

The Company is exposed to market risk related to changes in interest rates. The Company does not use derivative financial instruments for speculative or trading purposes.

The Company’s earnings are affected by changes in short-term interest rates as a result of its borrowings under its senior credit facilities.

At September 30, 2007, the fair value of the Company’s total debt, which has a carrying value of $632.6 million, was approximately $645.5 million. The Company had $417.6 million of variable debt outstanding at September 30, 2007. If the market interest rates for the Company’s variable rate borrowings had averaged 1% more subsequent to December 31, 2006, the Company’s interest expense would have increased, and earnings before income taxes would have decreased, by approximately $3.2 million for the nine months ended September 30, 2007. This analysis does not consider the effects of the reduced level of overall economic activity that could exist in such an environment. Further, in the event of a change of such magnitude, management could take actions in an attempt to further mitigate its exposure to the change. However, due to the uncertainty of the specific actions that would be taken and their possible effects, the sensitivity analysis assumes no changes in the Company’s financial structure. This level of interest rate exposure is consistent with the overall interest rate exposure at December 31, 2006.

35

Item 4. Controls and Procedures

The Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chairman and Chief Executive Officer, and Chief Financial Officer of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based upon that evaluation the Company’s Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures (1) were effective in timely alerting them to material information relating to the Company (including its consolidated subsidiaries) required to be included in the Company’s periodic SEC filings and (2) were adequate to ensure that information required to be disclosed by the Company in the reports filed or submitted by the Company under the Exchange Act is recorded, processed and summarized and reported within the time periods specified in the SEC’s rules and forms.

There have been no changes in the Company’s internal control over financial reporting identified in connection with the evaluation described in paragraph (a) above that have materially affected or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART 2. OTHER INFORMATION

Item 1. Legal Proceedings

We are currently a party to various legal proceedings. While we currently believe that the ultimate outcome of such proceedings, individually and in the aggregate, will not have a material adverse effect on our financial position or overall trends in results of operations, litigation is subject to inherent uncertainties. If an unfavorable ruling were to occur, there exists the possibility of a material adverse impact on our net earnings in the period in which the ruling occurs. The estimate of the potential impact from such legal proceedings on our financial position or overall results of operations could change in the future.

Item 1A. Risk Factors

There are no material changes from the risk factors as previously disclosed in our Form 10-K, filed with the Securities and Exchange Commission on March 13, 2007.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults upon Senior Securities

None.

Item 4. Submission of Matters to a Vote of Security Holders

None.

Item 5. Other Information

None.

36

Item 6. Exhibits

3.5	Article of Amendment to the Articles of Incorporation of Correctional Healthcare Advantage, Inc. dated May 11, 2007.
31.1	Certification by Lynn Massingale, M.D. for Team Finance LLC dated November 7, 2007 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification by David P. Jones for Team Finance LLC dated November 7, 2007 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.3	Certification by Lynn Massingale, M.D. for Health Finance Corporation dated November 7, 2007 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.4	Certification by David P. Jones for Health Finance Corporation dated November 7, 2007 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification by Lynn Massingale, M.D. for Team Finance LLC dated November 7, 2007 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification by David P. Jones for Team Finance LLC dated November 7, 2007 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.3	Certification by Lynn Massingale, M.D. for Health Finance Corporation dated November 7, 2007 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.4	Certification by David P. Jones for Health Finance Corporation dated November 7, 2007 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

37

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report on Form 10-Q to be signed on its behalf by the undersigned thereunto duly authorized.

TEAM FINANCE LLC

HEALTH FINANCE CORPORATION

/s/    H. LYNN MASSINGALE, M.D.        

H. Lynn Massingale, M.D.

Chief Executive Officer

November 7, 2007

/s/    DAVID P. JONES        

David P. Jones

Chief Financial Officer

November 7, 2007

38

EX-3.5

Exhibit 3.5

ARTICLES OF AMENDMENT TO THE ARTICLES OF INCORPORATION

OF

CORRECTIONAL HEALTHCARE ADVANTAGE, INC.

The undersigned Florida profit corporation, in accordance with Section 607.1006 of the Florida Business Corporation Act, hereby adopts the following Articles of Amendment to its Articles of Incorporation:

1. The name of the corporation is Correctional Healthcare Advantage, Inc.

2. The Articles of Incorporation are amended by the following resolution adopted by the shareholders on May 11, 2007:

RESOLVED, that the officers of the Corporation be, and they hereby are, authorized to take the necessary measures to amend the Corporation’s Articles of Incorporation by changing the name of the Corporation from Correctional Healthcare Advantage, Inc. to Paragon Emergency Services, Inc.

3. The First Article of the Corporation’s Articles of Incorporation is hereby amended in its entirety so as to read, after amendment, as follows:

FIRST: The name of the corporation (hereinafter called the “Corporation”) is Paragon Emergency Services, Inc.

4. This Amendment has been adopted by the unanimous written action of all of the Directors and Shareholders of the corporation dated as of the 11th day of May, 2007.

5. This Amendment shall be effective upon filing with the Florida Department of State.

IN WITNESS WHEREOF, the undersigned has executed and signed these Articles of Amendment on behalf of the corporation this 11^th day of May, 2007

By:
	John R. Stair
Its:	Assistant Secretary

EX-31.1

Exhibit 31.1

Certifications

I, H. Lynn Massingale, Chief Executive Officer of Team Finance LLC, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Team Finance LLC;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/    H. LYNN MASSINGALE, M.D.
	H. Lynn Massingale, M.D.
	Chief Executive Officer

Date: November 7, 2007

EX-31.2

Exhibit 31.2

Certifications

I, David P. Jones, Executive Chief Financial Officer of Team Finance LLC, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Team Finance LLC;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/    DAVID P. JONES
	David P. Jones
	Chief Financial Officer

Date: November 7, 2007

EX-31.3

Exhibit 31.3

Certifications

I, H. Lynn Massingale, Chief Executive Officer of Health Finance Corporation, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Health Finance Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/    H. LYNN MASSINGALE, M.D.
	H. Lynn Massingale, M.D.
	Chief Executive Officer

Date: November 7, 2007

EX-31.4

Exhibit 31.4

Certifications

I, David P. Jones, Executive Chief Financial Officer of Health Finance Corporation, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Health Finance Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/    DAVID P. JONES
	David P. Jones
	Chief Financial Officer

Date: November 7, 2007

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002*

In connection with the Quarterly Report of Team Finance LLC (the “Company”) on Form 10-Q (“Form 10-Q”) for the period ended September 30, 2007 as filed with the Securities and Exchange Commission on the date hereof, I, H. Lynn Massingale, M.D., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Form 10-Q fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/    H. LYNN MASSINGALE, M.D.        

H. Lynn Massingale, M.D.

Chief Executive Officer

Date: November 7, 2007

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002*

In connection with the Quarterly Report of Team Finance LLC (the “Company”) on Form 10-Q (“Form 10-Q”) for the period ended September 30, 2007 as filed with the Securities and Exchange Commission on the date hereof, I, David P. Jones, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Form 10-Q fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/    DAVID P. JONES        

David P. Jones

Chief Financial Officer

Date: November 7, 2007

EX-32.3

Exhibit 32.3

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002*

In connection with the Quarterly Report of Health Finance Corporation (the “Company”) on Form 10-Q (“Form 10-Q”) for the period ended September 30, 2007 as filed with the Securities and Exchange Commission on the date hereof, I, H. Lynn Massingale, M.D., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Form 10-Q fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/    H. LYNN MASSINGALE, M.D.        

H. Lynn Massingale, M.D.

Chief Executive Officer

Date: November 7, 2007

EX-32.4

Exhibit 32.4

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002*

In connection with the Quarterly Report of Health Finance Corporation (the “Company”) on Form 10-Q (“Form 10-Q”) for the period ended September 30, 2007 as filed with the Securities and Exchange Commission on the date hereof, I, David P. Jones, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Form 10-Q fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/    DAVID P. JONES        

David P. Jones

Chief Financial Officer

Date: November 7, 2007